The landscape of dementia analysis has developed dramatically with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-dependent checks that can detect Alzheimer's pathology a long time ahead of signs or symptoms arise. Though these technological advances signify exceptional progress in comprehension neurodegenerat